These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 34128879)

  • 21. Geometrical differences in target volumes based on 18F-fluorodeoxyglucose positron emission tomography/computed tomography and four-dimensional computed tomography maximum intensity projection images of primary thoracic esophageal cancer.
    Guo Y; Li J; Wang W; Zhang Y; Wang J; Duan Y; Shang D; Fu Z
    Dis Esophagus; 2014; 27(8):744-50. PubMed ID: 24915760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic tumor volume provides complementary prognostic information to EUS staging in esophageal and junctional cancer.
    Malik V; Johnston C; O'Toole D; Lucey J; O'Farrell N; Claxton Z; Reynolds JV
    Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27862622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of (18)F-fluorothymidine and (18)F-fluorodeoxyglucose PET/CT in delineating gross tumor volume by optimal threshold in patients with squamous cell carcinoma of thoracic esophagus.
    Han D; Yu J; Yu Y; Zhang G; Zhong X; Lu J; Yin Y; Fu Z; Mu D; Zhang B; He W; Huo Z; Liu X; Kong L; Zhao S; Sun X
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1235-41. PubMed ID: 19910143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Superior prognostic utility of gross and metabolic tumor volume compared to standardized uptake value using PET/CT in head and neck squamous cell carcinoma patients treated with intensity-modulated radiotherapy.
    Romesser PB; Qureshi MM; Shah BA; Chatburn LT; Jalisi S; Devaiah AK; Subramaniam RM; Truong MT
    Ann Nucl Med; 2012 Aug; 26(7):527-34. PubMed ID: 22610386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of different segmentation algorithms on metabolic tumor volume measured on 18F-FDG PET/CT of cervical primary squamous cell carcinoma.
    Xu W; Yu S; Ma Y; Liu C; Xin J
    Nucl Med Commun; 2017 Mar; 38(3):259-265. PubMed ID: 28118260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of PET standard uptake value and CT window-level thresholds for target delineation in CT-based radiation treatment planning.
    Hong R; Halama J; Bova D; Sethi A; Emami B
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):720-6. PubMed ID: 17293230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of intravoxel incoherent motion parameters in gastroesophageal cancer: relationship with 18F-FDG-positron emission tomography, computed tomography perfusion and magnetic resonance perfusion imaging parameters.
    Schawkat K; Sah BR; Ter Voert EE; Delso G; Wurnig M; Becker AS; Leibl S; Schneider PM; Reiner CS; Huellner MW; Veit-Haibach P
    Q J Nucl Med Mol Imaging; 2021 Jun; 65(2):178-186. PubMed ID: 31496202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of lymph node metastasis by PET/CT metabolic parameters in patients with esophageal squamous cell carcinoma.
    Xu M; Wang L; Ouyang M; Lin J; Wang L; Zheng X; Miao S; Tang K
    Nucl Med Commun; 2019 Sep; 40(9):933-939. PubMed ID: 31343610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diffusion-weighted MRI and
    Xu X; Sun ZY; Wu HW; Zhang CP; Hu B; Rong L; Chen HY; Xie HY; Wang YM; Lin HP; Bai YR; Ye Q; Ma XM
    Radiat Oncol; 2021 Jul; 16(1):132. PubMed ID: 34281566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accurate FDG PET tumor segmentation using the peritumoral halo layer method: a study in patients with esophageal squamous cell carcinoma.
    Jun S; Park JG; Seo Y
    Cancer Imaging; 2018 Sep; 18(1):35. PubMed ID: 30257714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The integration of 18-fluoro-deoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma.
    Konski A; Doss M; Milestone B; Haluszka O; Hanlon A; Freedman G; Adler L
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1123-8. PubMed ID: 15752892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer.
    Ashamalla H; Rafla S; Parikh K; Mokhtar B; Goswami G; Kambam S; Abdel-Dayem H; Guirguis A; Ross P; Evola A
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1016-23. PubMed ID: 15979817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of fiducial markers for target positioning in proton radiotherapy of oesophageal carcinoma.
    Apolle R; Brückner S; Frosch S; Rehm M; Thiele J; Valentini C; Lohaus F; Babatz J; Aust DE; Hampe J; Troost EGC
    Radiother Oncol; 2019 Apr; 133():28-34. PubMed ID: 30935578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma.
    Hyun SH; Choi JY; Shim YM; Kim K; Lee SJ; Cho YS; Lee JY; Lee KH; Kim BT
    Ann Surg Oncol; 2010 Jan; 17(1):115-22. PubMed ID: 19826877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variation in background intensity affects PET-based gross tumor volume delineation in non-small-cell lung cancer: the need for individualized information.
    Chen GH; Yao ZF; Fan XW; Zhang YJ; Gao HQ; Qian W; Wu KL; Jiang GL
    Radiother Oncol; 2013 Oct; 109(1):71-6. PubMed ID: 24060171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.
    Nestle U; Kremp S; Schaefer-Schuler A; Sebastian-Welsch C; Hellwig D; Rübe C; Kirsch CM
    J Nucl Med; 2005 Aug; 46(8):1342-8. PubMed ID: 16085592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of metabolic tumor volume and total lesion glycolysis in esophageal carcinoma patients treated with definitive chemoradiotherapy.
    Yildirim BA; Torun N; Guler OC; Onal C
    Nucl Med Commun; 2018 Jun; 39(6):553-563. PubMed ID: 29668513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of pretreatment metabolic tumor volumes on PET-CT to predict the survival of patients with squamous cell carcinoma of esophagus treated by curative surgery.
    Shum WY; Ding HJ; Liang JA; Yen KY; Chen SW; Kao CH
    Anticancer Res; 2012 Sep; 32(9):4163-8. PubMed ID: 22993379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of quantitative parameters for esophageal squamous cell carcinoma determined by preoperative FDG-PET after trimodal therapy.
    Hamai Y; Emi M; Ibuki Y; Murakami Y; Nishibuchi I; Nagata Y; Kurokawa T; Yoshikawa T; Hirohata R; Ohsawa M; Kitasaki N; Okada M
    Surgery; 2022 Aug; 172(2):584-592. PubMed ID: 35523595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor volume delineation in head and neck cancer with 18-fluor-fluorodeoxiglucose positron emission tomography: adaptive thresholding method applied to primary tumors and metastatic lymph nodes.
    Perez-Romasanta LA; Bellon-Guardia M; Torres-Donaire J; Lozano-Martin E; Sanz-Martin M; Velasco-Jimenez J
    Clin Transl Oncol; 2013 Apr; 15(4):283-93. PubMed ID: 22865325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.